Case Study and Clinical Highlight: Diagnosis of Pulmonary Involvement in Systemic Sclerosis

Case Study and Clinical Highlight: Diagnosis of Pulmonary Involvement in Systemic Sclerosis

Engage in this case study to test your diagnostic ability to differentiate pulmonary hypertension in the setting of systemic sclerosis.

Latest News

Scleroderma and Breast Cancer: Examining Outcomes of Radiation Therapy

Scleroderma and Breast Cancer: Examining Outcomes of Radiation Therapy

Researchers sought to determine the prevalence of radiation complications in patients with systemic scleroderma and breast cancer.

Stem Cell Transplant May Benefit Patients With Systemic Sclerosis

Stem Cell Transplant May Benefit Patients With Systemic Sclerosis

Patients who underwent autologous hematopoietic stem cell transplant for systemic sclerosis saw improvements in quality of life.

PAH Incidence in Systemic Sclerosis: Does Algorithm Use Affect Reported Incidence?

PAH Incidence in Systemic Sclerosis: Does Algorithm Use Affect Reported Incidence?

Use of the DETECT algorithm did not change incidence of PAH, but led to an increased frequency of cases of borderline pulmonary hypertension.

Early Scleroderma Disability May Be Affected by Skin Thickening, Poor Hand Function

Early Scleroderma Disability May Be Affected by Skin Thickening, Poor Hand Function

These results likely indicate the importance of skin thickening in contributing to impairment of hand function.

Patients With Early SSc-PAH Development Have Substantial Rate of Disease Progression

Patients With Early SSc-PAH Development Have Substantial Rate of Disease Progression

Patients with systemic sclerosis and early-diagnosed pulmonary arterial hypertension had disease progression over a relatively short period of time.

Predicting Mortality in Systemic Sclerosis-PAH With CT Signs of Veno-Occlusive Disease

Predicting Mortality in Systemic Sclerosis-PAH With CT Signs of Veno-Occlusive Disease

A blinded analysis sought to determine whether CT signs of pulmonary veno-occlusive disease are common and predictive of mortality in patients with systemic sclerosis and pulmonary arterial hypertension.

Assessment of Life Expectancy in Scleroderma-Associated Pulmonary Arterial Hypertension

Assessment of Life Expectancy in Scleroderma-Associated Pulmonary Arterial Hypertension

Patients with scleroderma-associated isolated pulmonary arterial hypertension (SSc-PAH) have a slightly higher mortality risk than patients SSc-PAH with concomitant interstitial lung disease.

Pulmonary Arterial Hypertension in Systemic Sclerosis: Swift Diagnosis and Effective Treatment

Pulmonary Arterial Hypertension in Systemic Sclerosis: Swift Diagnosis and Effective Treatment

Rheumatology specialists should be aware of the clinical features of SSc-PAH, as well as the tools available to facilitate a prompt, accurate diagnosis.

Key Hemodynamic Differences Noted With Scleroderma-Associated PAH vs Idiopathic PAH

Key Hemodynamic Differences Noted With Scleroderma-Associated PAH vs Idiopathic PAH

Patients with systemic sclerosis-associated pulmonary arterial hypertension display important differences in hemodynamic and pulmonary function parameters compared with patients with idiopathic PAH.

Systemic Sclerosis: Capillaroscopic and Ultrasonographic Evaluations

Systemic Sclerosis: Capillaroscopic and Ultrasonographic Evaluations

Microvascular damage evaluated using nailfold capillaroscopy and macrovascular features that include ulnar artery occlusion, assessed per hand power Doppler ultrasonography, have demonstrated associations with the main digital manifestations of systemic sclerosis.

Sign Up for Free e-newsletters